| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.027 | 0.6 |